మా గ్రూప్ ప్రతి సంవత్సరం USA, యూరప్ & ఆసియా అంతటా 3000+ గ్లోబల్ కాన్ఫరెన్స్ ఈవెంట్లను నిర్వహిస్తుంది మరియు 1000 కంటే ఎక్కువ సైంటిఫిక్ సొసైటీల మద్దతుతో 700+ ఓపెన్ యాక్సెస్ జర్నల్లను ప్రచురిస్తుంది , ఇందులో 50000 మంది ప్రముఖ వ్యక్తులు, ప్రఖ్యాత శాస్త్రవేత్తలు ఎడిటోరియల్ బోర్డ్ సభ్యులుగా ఉన్నారు.
ఎక్కువ మంది పాఠకులు మరియు అనులేఖనాలను పొందే ఓపెన్ యాక్సెస్ జర్నల్స్
700 జర్నల్స్ మరియు 15,000,000 రీడర్లు ప్రతి జర్నల్ 25,000+ రీడర్లను పొందుతున్నారు
Hua Liu, Nian Tan, Duo Xu, Chong-Yi Li and Guang-Jun Xian
Nerve growth factor (NGF) and ciliary neurotrophic factor (CNTF) are well known neurotrophic factors and widely used in the clinical treatment for its promotion effect on peripheral nerve regeneration. And they were also recommended for the acute paralytic strabismus treatment. However, whether the NGF and CNTF have protective effect for the extraocular muscles of acute paralytic strabismus patients is still poorly understood. Thus, in this study, we want to evaluate the biological function of NGF and CNTF on the extraocular muscle cells and revealed the regulation mechanism behind it. Firstly, the relative expression of ngf and cntf was assessed by Quantitative Realtime Polymerase Chain Reaction (RT-PCR). Then, the influence of NGF and CNTF on the extraocular muscle cell proliferation was determined by Cell Counting Kit-8 (CCK-8). The inflammatory response in muscle cells after NGF and CNTF treatment was evaluated by ELISA and Reactive Oxygen Species (ROS) detection. In addition to this, the up-stream regulation of the ngf and cntf expression was also studied. The TargetScan was used for the predication of potential miRNAs targeting with ngf and cntf 3’-UTR, which is soon confirmed by luciferase activity assay. Taken together, all the results above indicated that NGF and CNTF could promote the muscle cells proliferation and inhibit the inflammatory levels, then exert protective effect on the muscle cells function. It was conceivable that let 7-5p was the up-stream regulator of ngf and cntf, and let 7-5p might serve as a potential molecular target for acute paralytic strabismus treatment.